Eyegenex is a startup based in the United States, most recent round Pre-Seed.
Based in the United States, Eyegenex is a startup. Its most recent tracked round is Pre-Seed.
Eyegenex is developing novel pharmaceutical therapies targeting glaucoma, non-arteritic anterior ischemic optic neuropathy (NAION), and diabetic retinopathy to prevent vision loss and blindness.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.